News
BSX
44.96
-0.04%
-0.02
Boston Scientific price target lowered to $57 from $61 at Citi
TipRanks · 20m ago
Boston Scientific’s RESPI Study Signals Progress in Wearable Breathing Monitoring
TipRanks · 18h ago
Medtronic Raises 2027 Outlook as Broad-Based Growth Gains Momentum
NASDAQ · 21h ago
Imax To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Wednesday
Benzinga · 21h ago
Analysts Offer Insights on Healthcare Companies: BridgeBio Oncology Therapeutics (BBOT), Pharvaris (PHVS) and Boston Scientific (BSX)
TipRanks · 21h ago
Hack Fallout Means Boston Scientific to Miss Financial Targets
The Wall Street Journal · 23h ago
Boston Scientific Is Maintained at Buy by BTIG
Dow Jones · 23h ago
Boston Scientific Price Target Cut to $56.00/Share From $60.00 by BTIG
Dow Jones · 23h ago
BTIG Maintains Buy on Boston Scientific, Lowers Price Target to $56
Benzinga · 23h ago
Boston Scientific price target lowered to $56 from $60 at BTIG
TipRanks · 23h ago
2 Healthcare Stocks with Competitive Advantages and 1 We Question
Barchart · 1d ago
S&P Futures Slip as Bond Yields Climb After Oil Tops $100
Barchart · 1d ago
Boston Scientific Corp. Stock Slides 5.9%, Underperforms Peers
Dow Jones · 1d ago
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors
MarketWatch · 1d ago
Boston Scientific Says It Won't Meet 2026 Guidance After Cyberattack
Benzinga · 1d ago
Midday Fly By: Amazon dominates headlines with Qualcomm pact, cargo flight crash
TipRanks · 1d ago
Boston Scientific Lowers Full-Year Targets After Cyberattack
The Wall Street Journal · 1d ago
Stocks Settle Lower on Middle East Jitters
Barchart · 1d ago
Should Device Recalls Require Action From Boston Scientific Stock Investors?
Simply Wall St · 1d ago
Boston Scientific put volume heavy and directionally bearish
TipRanks · 1d ago
More
Webull provides a variety of real-time BSX stock news. You can receive the latest news about Boston Scien Cp through multiple platforms. This information may help you make smarter investment decisions.
About BSX
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology and vascular therapies (ICVT), watchman, cardiac rhythm management, and electrophysiology.